We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$371M
AUM Growth
-$19.1M
Cap. Flow
-$51.8M
Cap. Flow %
-13.97%
Top 10 Hldgs %
58.29%
Holding
41
New
8
Increased
14
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$9.08M
2
RMD icon
ResMed
RMD
+$7.64M
3
STJ
St Jude Medical
STJ
+$6.14M
4
BIIB icon
Biogen
BIIB
+$5.17M
5
HNT
HEALTH NET INC
HNT
+$4.34M

Top Sells

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$18.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$14.6M
3
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$12.9M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$10.4M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$9.45M

Sector Composition

Rank Sector Weight
1 Healthcare 88.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
26
United Therapeutics
UTHR
$22.5B
$4.4M 1.19%
38,910
+2,400
+7% +$216K
HNT
27
DELISTED
HEALTH NET INC
HNT
$4.3M 1.16%
+145,000
New +$4.34M
IART icon
28
Integra LifeSciences
IART
$1.47B
$3.39M 0.91%
+173,700
New +$3.19M
ACOR
29
DELISTED
Acorda Therapeutics
ACOR
$3.36M 0.91%
+958
New +$3.74M
THC icon
30
Tenet Healthcare
THC
$16.7B
$3.33M 0.9%
+79,000
New +$3.44M
ACH
31
Accendra Health
ACH
$254M
$2.93M 0.79%
80,084
-46,900
-37% -$1.72M
MNTA
32
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.42M 0.65%
136,800
-50,000
-27% -$840K
SPPI
33
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$443K 0.12%
50,000
– –
VRTX icon
34
Vertex Pharmaceuticals
VRTX
$122B
– –
-105,800
Closed -$8.02M
MNK
35
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-179,000
Closed -$7.89M
WCG
36
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-148,900
Closed -$10.4M
HSP
37
DELISTED
HOSPIRA INC
HSP
– –
-76,000
Closed -$2.98M
SLXP
38
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-141,301
Closed -$9.45M
VOLC
39
DELISTED
VOLCANO CORPORATION COM STK
VOLC
– –
-312,700
Closed -$7.49M
OPTR
40
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
– –
-376,393
Closed -$4.74M
ONXX
41
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
– –
-103,215
Closed -$12.9M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2013 Portfolio in Review

As of Q4 2013, Sector Gamma AS held 41 positions worth $371M, down 4.9% from $390M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sector Gamma AS withdrew a net $51.8M in Q4 2013, closing 8 positions and reducing 10 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 77% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Quest Diagnostics worth $8.2M.

  • Sector Gamma AS's largest Q4 2013 buy was Quest Diagnostics: 153,128 shares worth $8.2M.
  • Sector Gamma AS added most to UnitedHealth in Q4 2013, an estimated $4.07M increase.
  • Sector Gamma AS's biggest Q4 2013 reduction was FOREST LABORATORIES INC, cutting an estimated $18.4M.
  • Sector Gamma AS fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $12.9M.
  • Sector Gamma AS's ten largest holdings make up 58% of its $371M portfolio in Q4 2013.
  • Sector Gamma AS opened 8 new positions and closed 8 in Q4 2013.
  • Sector Gamma AS's portfolio value fell 4.9% quarter-over-quarter to $371M.

Based on Sector Gamma AS's 13F filing for Q4 2013, filed 14 Feb 2014.